Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Biopharma Market Research Report 2016

  • QYR821785
  • 110 Pages
  • December 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Production, means the output of Bio-pharma

Revenue, means the sales value of Bio-pharma

This report studies Bio-pharma in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

Pfizer

F. Hoffmann-La Roche AG

Johnson & Johnson Services

Sanofi, Amgen

AbbVie

Merck & Co., Inc

Biogen Idec

Bayer AG

Eli Lilly and Company

Novartis AG GlaxoSmithKline Plc

Bristol-Myers Squibb Company

AstraZeneca PLC

Abbott Laboratories

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Bio-pharma in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Japan

Southeast Asia

India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Monoclonal Antibodies

Recombinant Proteins

Granulocyte-Colony Stimulating Factor (G-CSF)

Interferons

Recombinant Human Insulin

Erythropoietin

Vaccines

Growth Hormones

Purified Proteins

Others

Split by application, this report focuses on consumption, market share and growth rate of Bio-pharma in each application, can be divided into

Metabolic Disorders

Oncology

Neurological Disorders

Cardiovascular Diseases

Inflammatory and Infectious Diseases

Others

Table of Contents

Global Bio-pharma Market Research Report 2016

1 Bio-pharma Market Overview

1.1 Product Overview and Scope of Bio-pharma

1.2 Bio-pharma Segment by Type

1.2.1 Global Production Market Share of Bio-pharma by Type in 2015

1.2.2 Monoclonal Antibodies

1.2.3 Recombinant Proteins

1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)

1.2.5 Interferons

1.2.6 Recombinant Human Insulin

1.2.7 Erythropoietin

1.2.8 Vaccines

1.2.9 Growth Hormones

1.2.10 Purified Proteins

1.2.11 Others

1.3 Bio-pharma Segment by Application

1.3.1 Bio-pharma Consumption Market Share by Application in 2015

1.3.2 Metabolic Disorders

1.3.3 Oncology

1.3.4 Neurological Disorders

1.3.5 Cardiovascular Diseases

1.3.6 Inflammatory and Infectious Diseases

1.3.7 Others

1.4 Bio-pharma Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Bio-pharma (2011-2021)

2 Global Bio-pharma Market Competition by Manufacturers

2.1 Global Bio-pharma Production and Share by Manufacturers (2015 and 2016)

2.2 Global Bio-pharma Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Bio-pharma Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Bio-pharma Manufacturing Base Distribution, Sales Area and Product Type

2.5 Bio-pharma Market Competitive Situation and Trends

2.5.1 Bio-pharma Market Concentration Rate

2.5.2 Bio-pharma Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Bio-pharma Production, Revenue (Value) by Region (2011-2016)

3.1 Global Bio-pharma Production and Market Share by Region (2011-2016)

3.2 Global Bio-pharma Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Bio-pharma Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Bio-pharma Consumption by Regions (2011-2016)

4.2 North America Bio-pharma Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Bio-pharma Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Bio-pharma Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Bio-pharma Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Bio-pharma Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Bio-pharma Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Bio-pharma Production, Revenue (Value), Price Trend by Type

5.1 Global Bio-pharma Production and Market Share by Type (2011-2016)

5.2 Global Bio-pharma Revenue and Market Share by Type (2011-2016)

5.3 Global Bio-pharma Price by Type (2011-2016)

5.4 Global Bio-pharma Production Growth by Type (2011-2016)

6 Global Bio-pharma Market Analysis by Application

6.1 Global Bio-pharma Consumption and Market Share by Application (2011-2016)

6.2 Global Bio-pharma Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Bio-pharma Manufacturers Profiles/Analysis

7.1 Pfizer

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Bio-pharma Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Pfizer Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 F. Hoffmann-La Roche AG

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Bio-pharma Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 F. Hoffmann-La Roche AG Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Johnson & Johnson Services

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Bio-pharma Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Johnson & Johnson Services Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 Sanofi, Amgen

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Bio-pharma Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 Sanofi, Amgen Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 AbbVie

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Bio-pharma Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 AbbVie Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Merck & Co., Inc

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Bio-pharma Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Merck & Co., Inc Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Biogen Idec

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Bio-pharma Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Biogen Idec Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Bayer AG

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Bio-pharma Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Bayer AG Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 Eli Lilly and Company

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Bio-pharma Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 Eli Lilly and Company Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 Novartis AG GlaxoSmithKline Plc

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 Bio-pharma Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

7.11 Bristol-Myers Squibb Company

7.12 AstraZeneca PLC

7.13 Abbott Laboratories

8 Bio-pharma Manufacturing Cost Analysis

8.1 Bio-pharma Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Bio-pharma

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Bio-pharma Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Bio-pharma Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Bio-pharma Market Forecast (2016-2021)

12.1 Global Bio-pharma Production, Revenue Forecast (2016-2021)

12.2 Global Bio-pharma Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Bio-pharma Production Forecast by Type (2016-2021)

12.4 Global Bio-pharma Consumption Forecast by Application (2016-2021)

12.5 Bio-pharma Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Bio-pharma

Figure Global Production Market Share of Bio-pharma by Type in 2015

Figure Product Picture of Monoclonal Antibodies

Table Major Manufacturers of Monoclonal Antibodies

Figure Product Picture of Recombinant Proteins

Table Major Manufacturers of Recombinant Proteins

Figure Product Picture of Granulocyte-Colony Stimulating Factor (G-CSF)

Table Major Manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF)

Figure Product Picture of Interferons

Table Major Manufacturers of Interferons

Figure Product Picture of Recombinant Human Insulin

Table Major Manufacturers of Recombinant Human Insulin

Figure Product Picture of Erythropoietin

Table Major Manufacturers of Erythropoietin

Figure Product Picture of Vaccines

Table Major Manufacturers of Vaccines

Figure Product Picture of Growth Hormones

Table Major Manufacturers of Growth Hormones

Figure Product Picture of Purified Proteins

Table Major Manufacturers of Purified Proteins

Figure Product Picture of Others

Table Major Manufacturers of Others

Table Bio-pharma Consumption Market Share by Application in 2015

Figure Metabolic Disorders Examples

Figure Oncology Examples

Figure Neurological Disorders Examples

Figure Cardiovascular Diseases Examples

Figure Inflammatory and Infectious Diseases Examples

Figure Others Examples

Figure North America Bio-pharma Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Bio-pharma Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Bio-pharma Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Bio-pharma Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Bio-pharma Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Bio-pharma Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Bio-pharma Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Bio-pharma Production of Key Manufacturers (2015 and 2016)

Table Global Bio-pharma Production Share by Manufacturers (2015 and 2016)

Figure 2015 Bio-pharma Production Share by Manufacturers

Figure 2016 Bio-pharma Production Share by Manufacturers

Table Global Bio-pharma Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Bio-pharma Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Bio-pharma Revenue Share by Manufacturers

Table 2016 Global Bio-pharma Revenue Share by Manufacturers

Table Global Market Bio-pharma Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Bio-pharma Average Price of Key Manufacturers in 2015

Table Manufacturers Bio-pharma Manufacturing Base Distribution and Sales Area

Table Manufacturers Bio-pharma Product Type

Figure Bio-pharma Market Share of Top 3 Manufacturers

Figure Bio-pharma Market Share of Top 5 Manufacturers

Table Global Bio-pharma Production by Regions (2011-2016)

Figure Global Bio-pharma Production and Market Share by Regions (2011-2016)

Figure Global Bio-pharma Production Market Share by Regions (2011-2016)

Figure 2015 Global Bio-pharma Production Market Share by Regions

Table Global Bio-pharma Revenue by Regions (2011-2016)

Table Global Bio-pharma Revenue Market Share by Regions (2011-2016)

Table 2015 Global Bio-pharma Revenue Market Share by Regions

Table Global Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Table China Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Table India Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Bio-pharma Consumption Market by Regions (2011-2016)

Table Global Bio-pharma Consumption Market Share by Regions (2011-2016)

Figure Global Bio-pharma Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Bio-pharma Consumption Market Share by Regions

Table North America Bio-pharma Production, Consumption, Import & Export (2011-2016)

Table Europe Bio-pharma Production, Consumption, Import & Export (2011-2016)

Table China Bio-pharma Production, Consumption, Import & Export (2011-2016)

Table Japan Bio-pharma Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Bio-pharma Production, Consumption, Import & Export (2011-2016)

Table India Bio-pharma Production, Consumption, Import & Export (2011-2016)

Table Global Bio-pharma Production by Type (2011-2016)

Table Global Bio-pharma Production Share by Type (2011-2016)

Figure Production Market Share of Bio-pharma by Type (2011-2016)

Figure 2015 Production Market Share of Bio-pharma by Type

Table Global Bio-pharma Revenue by Type (2011-2016)

Table Global Bio-pharma Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Bio-pharma by Type (2011-2016)

Figure 2015 Revenue Market Share of Bio-pharma by Type

Table Global Bio-pharma Price by Type (2011-2016)

Figure Global Bio-pharma Production Growth by Type (2011-2016)

Table Global Bio-pharma Consumption by Application (2011-2016)

Table Global Bio-pharma Consumption Market Share by Application (2011-2016)

Figure Global Bio-pharma Consumption Market Share by Application in 2015

Table Global Bio-pharma Consumption Growth Rate by Application (2011-2016)

Figure Global Bio-pharma Consumption Growth Rate by Application (2011-2016)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Bio-pharma Market Share (2011-2016)

Table F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table F. Hoffmann-La Roche AG Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure F. Hoffmann-La Roche AG Bio-pharma Market Share (2011-2016)

Table Johnson & Johnson Services Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Johnson & Johnson Services Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure Johnson & Johnson Services Bio-pharma Market Share (2011-2016)

Table Sanofi, Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi, Amgen Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi, Amgen Bio-pharma Market Share (2011-2016)

Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AbbVie Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure AbbVie Bio-pharma Market Share (2011-2016)

Table Merck & Co., Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck & Co., Inc Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure Merck & Co., Inc Bio-pharma Market Share (2011-2016)

Table Biogen Idec Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Biogen Idec Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure Biogen Idec Bio-pharma Market Share (2011-2016)

Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bayer AG Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer AG Bio-pharma Market Share (2011-2016)

Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lilly and Company Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure Eli Lilly and Company Bio-pharma Market Share (2011-2016)

Table Novartis AG GlaxoSmithKline Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis AG GlaxoSmithKline Plc Bio-pharma Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Bio-pharma

Figure Manufacturing Process Analysis of Bio-pharma

Figure Bio-pharma Industrial Chain Analysis

Table Raw Materials Sources of Bio-pharma Major Manufacturers in 2015

Table Major Buyers of Bio-pharma

Table Distributors/Traders List

Figure Global Bio-pharma Production and Growth Rate Forecast (2016-2021)

Figure Global Bio-pharma Revenue and Growth Rate Forecast (2016-2021)

Table Global Bio-pharma Production Forecast by Regions (2016-2021)

Table Global Bio-pharma Consumption Forecast by Regions (2016-2021)

Table Global Bio-pharma Production Forecast by Type (2016-2021)

Table Global Bio-pharma Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370